Results
hemorrhagic, ischemic stroke
ISCHEMIC STROKE
This study included 108 patients but two of them could not complete the four-week treatment protocol; hence they were excluded from the survey resulting in 106 patients. They were between ages 40–70 years with a mean age of 63.87±7.052 years comprising 62 (58.5%) males and 44 (41.5%) females. The affected part was the right side upper limb of 68 (64.2%) and left side of 38 (35.8%). Of them, 74 (69.8%) of ischemic stroke patients and 32 hemorrhagic patients (30.2%) and were assigned to two treatment groups as experimental (rESWT: 53 (50%)) and control (TENS: 53 (50%)), resulting in four major patients treatment groups: ischemic rESWT: 37 (34.9%), ischemic TENS: 37 (34.9%), hemorrhagic rESWT: 16 (15.1%) and, hemorrhagic TENS: 16 (15.1%). The baseline characteristics of the participants are included in 